Advertisement
Screener

aTYR PHARMA INC (ATYR) ROI

aTYR PHARMA INC (ATYR) ROI

  • 2019-09-30: ROI -64.18%.
  • 2019-06-30: ROI -59.61%.
  • 2019-03-31: ROI -68.59%.
  • 2018-12-31: ROI -69.47%.

Complete source-backed roi history.

Available history
2015-12-31 to 2019-09-30
Data captured

Historical ROI

DateROI
2019-09-30-64.18%
2019-06-30-59.61%
2019-03-31-68.59%
2018-12-31-69.47%
2018-09-30-69.84%
2018-06-30-67.36%
2018-03-31-61.05%
2017-12-31-57.41%
2017-09-30-56.64%
2017-06-30-95.09%
2017-03-31-91.53%
2016-12-31-79.98%
2015-12-31-39.91%

Annual ROI

DateROI
2018-12-31-69.47%
2017-12-31-57.41%
2016-12-31-79.98%
2015-12-31-39.91%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Scilex Holding Co (SCLX)United States$0.042B-0.14
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
BioCardia, Inc. (BCDA)United States$0.016B